Crizotinib Versus Conventional Chemotherapy in First-Line Treatment for ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

INTRODUCTION: Lung cancer is the most frequently diagnosed type of cancer and the main cause of death from malignant neoplasms worldwide. One of the most recent discoveries in the context of non-small cell lung cancer (NSCLC) was the mutation of the anaplastic lymphoma kinase receptor (ALK). This ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz, Barbara D., Barbosa, Mariana M., Torres, Lucas L., Azevedo, Pamela S., Silva, Vânia E. A., Godman, Brian, Alvares-Teodoro, Juliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594233/
https://www.ncbi.nlm.nih.gov/pubmed/34117602
http://dx.doi.org/10.1007/s40487-021-00155-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594233/
https://www.ncbi.nlm.nih.gov/pubmed/34117602
http://dx.doi.org/10.1007/s40487-021-00155-3

Ejemplares similares